Tian Chi

Years Active: 2020-2021
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Yongqin Li, Yuxin Chen, Shaoshuai Mao, Ravinder Kaundal, Zhengyu Jing, Qin Chen, Xinxin Wang, Jing Xia, Dahai Liu, Jianlong Sun, Haopeng Wang, Tian Chi
Author Correction: In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice. Nature communications 12 (1) (2021)
Yajing Liu, Changyang Zhou, Shisheng Huang, Lu Dang, Yu Wei, Jun He, Yingsi Zhou, Shaoshuai Mao, Wanyu Tao, Yu Zhang, Hui Yang, Xing-Xu Huang, Tian Chi
A Cas-embedding strategy for minimizing off-target effects of DNA base editors. Nature communications 11 (1) (2020)
Yajing Liu, Shaoshuai Mao, Shisheng Huang, Yongqin Li, Yuxin Chen, Minghui Di, Xinxin Huang, Junjun Lv, Xinxin Wang, Jianyang Ge, Shengxi Shen, Xiaoming Zhang, Dahai Liu, Xingxu Huang, Tian Chi
REPAIRx, a specific yet highly efficient programmable A > I RNA base editor. The EMBO journal 39 (22) (2020)
Yongqin Li, Yuxin Chen, Shaoshuai Mao, Ravinder Kaundal, Zhengyu Jing, Qin Chen, Xinxin Wang, Jing Xia, Dahai Liu, Jianlong Sun, Haopeng Wang, Tian Chi
In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice. Nature communications 11 (1) (2020)
Xinxin Huang, Junjun Lv, Yongqin Li, Shaoshuai Mao, Zhifang Li, Zhengyu Jing, Yidi Sun, Xiaoming Zhang, Shengxi Shen, Xinxin Wang, Minghui Di, Jianyang Ge, Xingxu Huang, Erwei Zuo, Tian Chi
Programmable C-to-U RNA editing using the human APOBEC3A deaminase. The EMBO journal 39 (22) (2020)

Tian Chi.css-eqlu8i{font-size:small;padding-left:4px;}